Service Description

The CRO was engaged to conduct a trial for a new formulation of a thereapeutic haemophilia medicine, based on a freeze-dried coagulation factor.

What Went Well

The approporate patient group was assembled; the trial was executed on time; reports and data analysis were appropriate and of good quality.

What Could Be Improved

There was nothing that really could have been improved, the service provided by the CRO met our requirements and was good.

Lessons Learned from the Experience

The CRO provided helpful advice, especially in designing the study so that robust statistical analysis could be performed at the end.